Genc, S. Et Al. 2019. Does Picnogenol and Melatonin Combination Decrease Tumor Cells Viability in Comparison to Platin Base Anti-Cancer Drug?. ACTA PHYSIOLOGICA , vol.227 , 71.

Genc, S., Taghızadehghalehjoughı, A., Yeni, Y., Hacımüftüoğlu, A., & Çakır, Z., (2019). Does Picnogenol and Melatonin Combination Decrease Tumor Cells Viability in Comparison to Platin Base Anti-Cancer Drug?. ACTA PHYSIOLOGICA , vol.227, 71.

Genc, Sidika Et Al. "Does Picnogenol and Melatonin Combination Decrease Tumor Cells Viability in Comparison to Platin Base Anti-Cancer Drug?," ACTA PHYSIOLOGICA , vol.227, 71, 2019

Genc, Sidika Et Al. "Does Picnogenol and Melatonin Combination Decrease Tumor Cells Viability in Comparison to Platin Base Anti-Cancer Drug?." ACTA PHYSIOLOGICA , vol.227, pp.71, 2019

Genc, S. Et Al. (2019) . "Does Picnogenol and Melatonin Combination Decrease Tumor Cells Viability in Comparison to Platin Base Anti-Cancer Drug?." ACTA PHYSIOLOGICA , vol.227, p.71.

@article{article, author={Sidika Genc Et Al. }, title={Does Picnogenol and Melatonin Combination Decrease Tumor Cells Viability in Comparison to Platin Base Anti-Cancer Drug?}, journal={ACTA PHYSIOLOGICA}, year=2019, pages={71} }